Levothyroxine Sodium
Product Images NDC 70934-901

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 70934-901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 901 30 Master Bottle Label Approval Rev A 12 21)

Label for Levothyroxine Sodium Tablets, USP 175 mcg (0.175 mg), containing 30 tablets. The label includes storage instructions, dosage note to see package insert, and manufacturer information listing Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The NDC is 70934-901-30.*

FDA Label Image

Description (Levothyroxine Str)

Chemical structure diagram of Levothyroxine sodium showing molecular groups including iodine atoms, hydroxyl group, and sodium carboxylate with water of hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.